What is the recommended dose of imipenem and metronidazole for an 11-year-old patient weighing 50kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosing Recommendations for Imipenem and Metronidazole in an 11-Year-Old, 50kg Patient

For this 11-year-old patient weighing 50kg, imipenem should be dosed at 1000-1250 mg (20-25 mg/kg) every 6 hours intravenously, and metronidazole should be dosed at 1500 mg (30 mg/kg) once daily intravenously or 500 mg every 8 hours.

Imipenem Dosing

Standard Pediatric Dosing

  • The British Thoracic Society guidelines recommend 20-40 mg/kg (maximum 2g) three times daily intravenously for children 1.
  • For a 50kg patient, this translates to 1000-2000 mg every 8 hours 1.

Weight-Based Considerations

  • Since this patient weighs exactly 50kg, they fall into a transitional category where both pediatric and adult dosing may apply 1.
  • The Infectious Diseases Society of America guidelines specify that adults >50kg should receive 1g twice daily, while adults <50kg should receive 15 mg/kg twice daily 1.
  • However, for serious infections including complicated intra-abdominal infections, doses of 750 mg three times daily have been used in adults 1.

Optimized Dosing Based on Pharmacokinetics

  • Recent population pharmacokinetic studies in children demonstrate that 25 mg/kg every 6 hours (100 mg/kg/day) via 1.5-hour infusions is required for adequate coverage against Pseudomonas aeruginosa 2.
  • For this 50kg patient, this would be 1250 mg every 6 hours 2.
  • Standard dosing of 15-25 mg/kg every 6 hours (750-1250 mg every 6 hours) is sufficient against most common bacterial isolates 1, 2.

Practical Recommendation

Dose imipenem at 1000 mg every 6 hours for most infections, or 1250 mg every 6 hours for suspected Pseudomonas or resistant organisms 1, 2.

Metronidazole Dosing

Standard Pediatric Dosing

  • The IDSA guidelines recommend 30-40 mg/kg/day divided every 8 hours for pediatric patients 1.
  • For a 50kg patient, this translates to 500 mg every 8 hours (1500 mg/day total) 1.

Once-Daily Dosing Option

  • Recent pharmacokinetic-pharmacodynamic studies in pediatric appendicitis patients demonstrate that 30 mg/kg once daily (1500 mg for this patient) achieves adequate target attainment against Bacteroides fragilis with MIC ≤2 mcg/mL 3.
  • This once-daily dosing achieved similar AUC values to adults receiving standard dosing regimens 3.

Practical Recommendation

Either 1500 mg once daily OR 500 mg every 8 hours is appropriate 1, 3. The once-daily regimen offers convenience and similar efficacy for most anaerobic infections 3.

Important Clinical Considerations

Renal Function Monitoring

  • Dose reduction may be necessary in renal failure for both medications 1.
  • Routine toxicity monitoring (CBC, renal function, liver function) should be performed intermittently throughout treatment 1.

Imipenem-Specific Warnings

  • Seizure risk increases with imipenem, particularly in patients with renal insufficiency or CNS disease 1, 4, 5.
  • Avoid concomitant use with valproate as imipenem reduces valproate serum concentrations 1.
  • Increased seizure risk with concurrent ganciclovir 1.

Infusion Considerations

  • Imipenem should be infused over at least 30 minutes to 1 hour to minimize infusion-related nausea and vomiting 4, 2.
  • Extended infusions (1.5 hours) may improve pharmacodynamic target attainment against resistant organisms 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Imipenem.

Mayo Clinic proceedings, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.